Committed to responsible pain management

Developing innovative and differentiated products for people suffering from pain

At Collegium Pharmaceutical we are committed to being the leader in responsible pain management. We have developed a portfolio of meaningfully differentiated products for use in the treatment of moderate to severe pain.

News and Press

Join the Collegium team

See Job Listings

News and Press

  • Collegium Reports Full-Year 2019 Revenue of $296.7 Million

    Read More
  • Collegium to Host Conference Call to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Provide Corporate Update

    Read More
  • Collegium Announces Closing of the Nucynta Franchise Acquisition

    Read More
  • Collegium Pharmaceutical, Inc. Prices $125.0 Million Convertible Senior Notes Offering

    Read More